Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Dallas92on Jan 17, 2018 3:27pm
157 Views
Post# 27379499

RE:I WAS WRONG ABOUT CMED!

RE:I WAS WRONG ABOUT CMED!

FOCUS2WIN wrote: It appears many are willing to pay $3.00 over the ACB offer of $24? 
Maybe the deal does not happen?
Friday could determine all...

btw, ACB long.
F2W


Their voume for the day as of right now is 362,900. Compared to to APH which is 4.3 million, Canopy which is 5.2 million, and ACB which is 11.2 million. Almost no one is trading Canni-med from what I can tell. I'd be willing to be most of their volume is ACB buying the rest of their shares. Really makes no difference if you ask me, whatever their SP is we won't pay more than $24 for them. Hypothetically even if we didn't their SP will crash back down to near $12 to what it ACTUALLY should be before we put in a hostile takeover bid. Part of me wants this deal to not go through just so it will silence the ignorance of the Canni-med investors. They think they earned $27+ a share... they didn't. They have been riding the ACB wave, I still feel strongly that we're going to aquire them.

Time will tell....

ACB for the win!

Bullboard Posts